Karen Walker
Chief Tech/Sci/R&D Officer at KYVERNA THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Profile
Karen Walker is currently the Chief Technology Officer at Kyverna Therapeutics, Inc. She is also a member of the Parenteral Drug Association, Alliance For Regenerative Medicine’s Foundation, and PDA ATMP Working Group.
Previously, she held the position of Vice President at Novartis, Inc. and Seagen Inc. Ms. Walker received her undergraduate degree from St. Olaf College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Karen Walker active positions
| Companies | Position | Start |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2021 |
| Alliance For Regenerative Medicine’S Foundation | Corporate Officer/Principal | - |
| Parenteral Drug Association | Corporate Officer/Principal | - |
Former positions of Karen Walker
| Companies | Position | End |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
| SEAGEN INC. | Corporate Officer/Principal | - |
Training of Karen Walker
| St. Olaf College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
| Parenteral Drug Association | |
| Alliance For Regenerative Medicine’S Foundation |
- Stock Market
- Insiders
- Karen Walker
